Qidwai, T: Drug Repurposing Against SARS-CoV-2. Cet article n’est pas disponible.
Langue : anglais
Edité par Amazon Digital Services LLC - Kdp, 2023
- Livre broché
- Neuf
Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH
Vendeur avec une évaluation de 5 étoiles
Vendeur AbeBooks depuis 14 août 2006
Indisponible
Livre broché
Etat: Neuf
EUR 91,33
A propos de cet article
Neuware - Drug repurposing is a cost-effective method of discovering new treatments for diseases than traditional drug development methods. It involves virtual screening of chemical candidates with the aid of computational methods like molecular docking.
N° de réf. du vendeur 9789815123210
- Titre
- Qidwai, T: Drug Repurposing Against SARS-CoV-2
- Auteur
- Tabish Qidwai
- Éditeur
- Amazon Digital Services LLC - Kdp
- Année de publication
- 2023
- État de l'article
- Neu
- Reliure
- Taschenbuch
- Langue
- anglais
- ISBN à 10 chiffres
- 9815123211
- ISBN à 13 chiffres
- 9789815123210
- Poids de l'article
- 503 grammes
- Dimensions
- 254x178x14 mm
Drug repurposing is a cost-effective method of discovering new treatments for diseases than traditional drug development methods. It involves virtual screening of chemical candidates with the aid of computational methods like molecular docking.
Drug Repurposing against SARS-CoV2 focuses on current trends in drug repurposing against the novel coronavirus strains. The book aims to give readers an overview of drug repurposing against COVID-19 and various techniques involved in the process. The book consolidates available information on the pathophysiology, drug targets, and drug repurposing against COVID-19 into a single, convenient resource.
Key features
• An up-to-date compilation of the evidence that supports the drug repurposing for COVID-19.
• How to use repurposing of available drugs for disease therapy.
• Provides an improved understanding of pathophysiology and SARS-CoV2 viral entry pathways.
• Provides references for further reading
Drug Repurposing against SARS-CoV2 focuses on current trends in drug repurposing against the novel coronavirus strains. The book aims to give readers an overview of drug repurposing against COVID-19 and various techniques involved in the process. The book consolidates available information on the pathophysiology, drug targets, and drug repurposing against COVID-19 into a single, convenient resource.
Key features
• An up-to-date compilation of the evidence that supports the drug repurposing for COVID-19.
• How to use repurposing of available drugs for disease therapy.
• Provides an improved understanding of pathophysiology and SARS-CoV2 viral entry pathways.
• Provides references for further reading
« Synopsis » peut appartenir à une autre édition de cet ouvrage.